Skip to main content
SpringerLink
Log in

Gewichtsreduktion unter Gliflozin-Therapie bei Typ-2-Diabetes

Weight loss with gliflozine therapy in type 2 diabetes

  • Journal Club
  • Published:
Der Diabetologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

  1. Institut für klinische Diabetologie, Deutsches Diabetes-Zentrum an der Heinrich-Heine-Universität, Leibniz-Zentrum für Diabetesforschung, Auf’m Hennekamp 65, 40225, Düsseldorf, Deutschland

    S. Kahl

Authors
  1. S. Kahl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Kahl.

Ethics declarations

Interessenkonflikt

S. Kahl gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kahl, S. Gewichtsreduktion unter Gliflozin-Therapie bei Typ-2-Diabetes. Diabetologe 15, 265–266 (2019). https://doi.org/10.1007/s11428-019-0470-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11428-019-0470-z

Search

Navigation